Correcting Genetic Spelling Errors With Next-Generation Crispr
Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of the genome.
Read MoreDr. Reshma Kewalramani
Company: Vertex PharmaceuticalsTitle: President & CEOIndustry: PharmaceuticalsNotable in 2024: Dr. Kewalramani won regulatory approval for its...
Read More
Your Next Pet Could Be a Glowing Rabbit
Biohacker Josie Zayner’s new company, the Los Angeles Project, is using gene-editing to create a new generation of pets.
Read More
NHS to get access to gene editing therapy for sickle cell disease
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant access to gene-editing...
Read MoreEnd of content
No more pages to load